232 related articles for article (PubMed ID: 32067794)
21. Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767-8.
Godtman RA; Stranne J; Hugosson J
Eur Urol; 2016 Nov; 70(5):769-770. PubMed ID: 27210462
[No Abstract] [Full Text] [Related]
22. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.
van der Poel HG; Buckle T; Valdes Olmos R
Eur Urol; 2013 Feb; 63(2):e20. PubMed ID: 23153744
[No Abstract] [Full Text] [Related]
23. Reply to Roderick C.N. van den Bergh, Massimo Valerio, Derya Tilki, and Giorgio Gandaglia's Letter to the Editor re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2020.02.009.
Wilt TJ; Dahm P; Brawer MK
Eur Urol; 2020 Aug; 78(2):e69-e70. PubMed ID: 32303386
[No Abstract] [Full Text] [Related]
24. Reply to Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4.
Beck TN; Golemis EA; Geynisman DM
Eur Urol; 2016 Sep; 70(3):e75-6. PubMed ID: 26947605
[No Abstract] [Full Text] [Related]
25. Reply to Jérôme Verine's letter to the editor Re: Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, Marina Scarpelli. Re: Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur Urol 2013;63:400-1.
Montironi R; Lopez-Beltran A; Cheng L; Scarpelli M
Eur Urol; 2013 Jun; 63(6):e74-5. PubMed ID: 23473578
[No Abstract] [Full Text] [Related]
26. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013;63:450-8.
Kim KH; Rha KH
Eur Urol; 2013 Sep; 64(3):e55-6. PubMed ID: 23746720
[No Abstract] [Full Text] [Related]
27. Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Moris L; Van den Broeck T; Wiegel T;
Eur Urol; 2020 Sep; 78(3):e120-e121. PubMed ID: 32684306
[No Abstract] [Full Text] [Related]
28. Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Moris L; Mottet N; Wiegel T
Eur Urol; 2020 Sep; 78(3):e116-e117. PubMed ID: 32536484
[No Abstract] [Full Text] [Related]
29. Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83.
Fanti S; Krause B; Weber W; Castellucci P; Grosu AL; de Jong IJ; Messa C; Picchio M; Pruim J; Langsteger W; Chiti A;
Eur Urol; 2011 Nov; 60(5):e37-8; author reply e39-41. PubMed ID: 21855205
[No Abstract] [Full Text] [Related]
30. Re: Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4.
Ruiz-Bañobre J; Anido U; García-González J
Eur Urol; 2017 Jan; 71(1):e26. PubMed ID: 27417030
[No Abstract] [Full Text] [Related]
31. Reply to Giorgio Gandaglia, Alberto Briganti, Daniele Raggi, et al's Letter to the Editor re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
Hoeh B; Chun FKH; Mandel P
Eur Urol Focus; 2023 Feb; ():. PubMed ID: 36813619
[No Abstract] [Full Text] [Related]
32. Re: Kenneth A. Iczkowski's Letter to the Editor re: Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5.
Montironi R; Lopez-Beltran A; Cheng L; Gasparrini S; Montironi MA; Massari F; Scarpelli M; Montorsi F
Eur Urol; 2017 Aug; 72(2):e37-e38. PubMed ID: 28292549
[No Abstract] [Full Text] [Related]
33. Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al's Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e53.
Leibowitz-Amit R
Eur Urol; 2019 Jul; 76(1):e19. PubMed ID: 30928161
[No Abstract] [Full Text] [Related]
34. Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274.
Abel EJ; Master VA; Spiess PE; Raman JD; Shapiro DD; Sexton WJ; Zemp L; Patil D; Lauer K; Allen GO; Matin SF; Karam JA
Eur Urol Oncol; 2024 Apr; 7(2):302-303. PubMed ID: 38000932
[No Abstract] [Full Text] [Related]
35. Reply to Vincenzo Di Nunno, Matteo Santoni, Alessia Cimadamore, Nicola Battelli, and Francesco Massari's Letter to the Editor re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, et al. Updates in the Eight Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560-9.
Paner GP; Amin MB
Eur Urol; 2018 Nov; 74(5):e120-e121. PubMed ID: 30057129
[No Abstract] [Full Text] [Related]
36. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Funada S; Yoshioka T; Luo Y
Eur Urol; 2020 Sep; 78(3):e118-e119. PubMed ID: 32682614
[No Abstract] [Full Text] [Related]
37. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Gregucci F; Carbonara R; Fiorentino A
Eur Urol; 2020 Sep; 78(3):e114-e115. PubMed ID: 32534911
[No Abstract] [Full Text] [Related]
38. Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
Hamdy FC; Donovan JL
Eur Urol; 2024 Feb; 85(2):e41-e42. PubMed ID: 37659961
[No Abstract] [Full Text] [Related]
39. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Montorsi F; Salonia A; Briganti A
Eur Urol; 2020 Nov; 78(5):e192. PubMed ID: 32800728
[No Abstract] [Full Text] [Related]
40. Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5.
Iczkowski KA
Eur Urol; 2017 Aug; 72(2):e36. PubMed ID: 28284740
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
